Rep. Waxman Statement on the Supreme Court Ruling in Caraco v. Novo
Ranking Member Henry A. Waxman released the following statement in response to the Supreme Court’s decision in the Caraco Pharmaceutical v. Novo Nordisk case:
“I welcome the decision by the U.S. Supreme Court on the Caraco v. Novo case. While the issues in the case may seem arcane, the fact of the matter is that allowing brand companies to exaggerate the breadth of their patent protections in their listings with FDA served as a real block to generics. I am pleased that the courts unanimously agreed with that view. This decision is in the interest of American consumers who should have the benefit of competition and lower prices.”
Rep. Waxman filed an amicus brief with the Court in September 2011 that is posted below.
- 1 of 86